{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T08:52:18Z","timestamp":1781686338265,"version":"3.54.5"},"reference-count":11,"publisher":"Norwegian Medical Association","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"DOI":"10.4045\/tidsskr.19.0765","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T04:42:58Z","timestamp":1603082578000},"source":"Crossref","is-referenced-by-count":1,"title":["A man in his fifties with increasing motor fluctuations, sleep impairment and altered mental status"],"prefix":"10.4045","volume":"140","author":[{"given":"Ingrid","family":"Nysveen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirza","family":"Jusufovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svein Martin","family":"Luth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidar","family":"Gundersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger Marie","family":"Skogseid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","published-online":{"date-parts":[[2020,10,8]]},"reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"LeWitt\u00a0PA. Levodopa therapy for Parkinson's disease: Pharmacokinetics and pharmacodynamics. Mov Disord 2015; 30: 64\u201372. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=25449210&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002%2Fmds.26082","DOI":"10.1002\/mds.26082"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"Ferreira\u00a0JJ, Katzenschlager\u00a0R, Bloem\u00a0BR et al. Summary of the recommendations of the EFNS\/MDS-ES review on therapeutic management of Parkinson's disease. Eur J Neurol 2013; 20: 5\u201315. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=23279439&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111%2Fj.1468-1331.2012.03866.x","DOI":"10.1111\/j.1468-1331.2012.03866.x"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"Tomlinson\u00a0CL, Stowe\u00a0R, Patel\u00a0S et al. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010; 25: 2649\u201353. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21069833&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002%2Fmds.23429","DOI":"10.1002\/mds.23429"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"Ffytche\u00a0DH, Creese\u00a0B, Politis\u00a0M et al. The psychosis spectrum in Parkinson disease. Nat Rev Neurol 2017; 13: 81\u201395. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=28106066&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1038%2Fnrneurol.2016.200","DOI":"10.1038\/nrneurol.2016.200"},{"key":"ref=5","unstructured":"Delay\u00a0J, Pichot\u00a0P, Lemperiere\u00a0T et al. A non-phenothiazine and non-reserpine major neuroleptic, haloperidol, in the treatment of psychoses. Ann Med Psychol (Paris) 1960; 118: 145\u201352. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=13815606&dopt=Abstract"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Rajan\u00a0S, Kaas\u00a0B, Moukheiber\u00a0E. Movement Disorders Emergencies. Semin Neurol 2019; 39: 125\u201336. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=30743298&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1055%2Fs-0038-1677050","DOI":"10.1055\/s-0038-1677050"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Andersen\u00a0K, Balldin\u00a0J, Gottfries\u00a0CG et al. A double-blind evaluation of electroconvulsive therapy in Parkinson's disease with \"on-off\" phenomena. Acta Neurol Scand 1987; 76: 191\u20139. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2446463&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111%2Fj.1600-0404.1987.tb03566.x","DOI":"10.1111\/j.1600-0404.1987.tb03566.x"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"Rosenquist\u00a0PB, Youssef\u00a0NA, Surya\u00a0S et al. When all else fails: The use of electroconvulsive therapy for conditions other than major depressive episode. Psychiatr Clin North Am 2018; 41: 355\u201371. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=30098650&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.psc.2018.04.002","DOI":"10.1016\/j.psc.2018.04.002"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"Ozer\u00a0F, Meral\u00a0H, Aydin\u00a0B et al. Electroconvulsive therapy in drug-induced psychiatric states and neuroleptic malignant syndrome. J ECT 2005; 21: 125\u20137. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15905757&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1097%2F01.yct.0000159325.08303.45","DOI":"10.1097\/01.yct.0000159325.08303.45"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"Takubo\u00a0H, Harada\u00a0T, Hashimoto\u00a0T et al. A collaborative study on the malignant syndrome in Parkinson's disease and related disorders. Parkinsonism Relat Disord 2003; 9 (suppl 1): S31\u201341. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12735913&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2FS1353-8020(02)00122-0","DOI":"10.1016\/S1353-8020(02)00122-0"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"Mizuno\u00a0Y, Takubo\u00a0H, Mizuta\u00a0E et al. Malignant syndrome in Parkinson's disease: concept and review of the literature. Parkinsonism Relat Disord 2003; 9 (suppl 1): S3\u20139. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12735909&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2FS1353-8020(02)00125-6","DOI":"10.1016\/S1353-8020(02)00125-6"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":["En mann i 50-\u00e5rene med \u00f8kende motoriske svingninger, s\u00f8vnvansker og mental endring"],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T07:56:30Z","timestamp":1781682990000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2020\/10\/noe-laere-av\/en-mann-i-50-arene-med-okende-motoriske-svingninger-sovnvansker-og-mental"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,8]]},"references-count":11,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2020,10,13]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.19.0765","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,8]]}}}